1K
Downloads
55
Episodes
Canadian broadcasting veteran Jody Vance talks to the leaders of some of North America's most innovative public companies, from tech to e-sports to mining to biotech and beyond. If you're less interested in balance sheets and more intrigued by people, origin stories, and their own investing philosophies, First Glance should be your first podcast every morning. Subscribe today!
Episodes
Friday Jul 09, 2021
Friday Jul 09, 2021
Deborah Rathjen, CEO of Bioasis Technologies (BTI.V) talks about the company's ground-breaking xB3 platform which allows therapeutic drugs to pass through the seemingly impenetrable blood-brain barrier, providing an effective treatment methodology for such neurological disorders as Alzheimer's disease, Lewy Body Dementia and Parkinson's. In short, Bioasis' final frontier solution could very well revolutionize medical science, potentially helping to heal the one billion people suffering from neurological disorders worldwide. Tune in!
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.